Close Menu

University of Oxford

Balancing the Two

The Economist reports on an approach used by UK researchers to study medical records while protecting patient privacy.

Independent teams reported on apparent SARS-CoV-2 transmission events in China's Guangdong province and in Connecticut, using genome sequence, travel, and epidemiology data.

University of Oxford researchers said they are weeks away from completing clinical validation of a coronavirus molecular test based on RT-LAMP technology.

A four-year, $5.5 million program will assess whether circulating cell-free DNA testing can improve diagnosis and outcomes for a type of EBV-associated cancer.

In Nature this week: epigenetic factors that prevent healthy aging and more.

In PNAS this week: extrachromosomal circular DNA in pregnant women's blood plasma, mutation accumulation limited by tissue compartment size, and more.

Genotypes for more than 12,000 individuals from the Americas revealed contributions from European colonization, the Atlantic slave trade, and other migrations.

The project represents the UK portion of a broader initiative to sequence the genomes of all 1.5 million known animals, plants, protozoa, and fungi.

Three researchers have won this year's Nobel Prize in Medicine or Physiology for their work uncovering how cells react to changing oxygen levels.

In Science this week: four reviews examine what's known about the associations between genotype and phenotype, and more.

Pages

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

Direct-to-consumer genetic testing companies searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.